TIARA WARD: Open Payments
NPI 1811607245 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 41 payments from 13 companies in 2025. Trend: 2023 $15 · 2024 $0 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $205 |
| Madrigal Pharmaceuticals | 4 | $146 |
| SANOFI-AVENTIS U.S. LLC | 1 | $121 |
| Janssen Biotech, Inc. | 5 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $33 |
| Pharmacosmos Therapeutics Inc. | 1 | $29 |
| Ardelyx, Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: REZDIFFRA, TZIELD, TREMFYA, RINVOQ, LINZESS, XIFAXAN, Wegovy, ENTYVIO.
Industry payments across OH — which companies pay providers there.
